logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Annual Reports In Medicinal Chemistry Vol 40 Annette M Doherty

  • SKU: BELL-1123826
Annual Reports In Medicinal Chemistry Vol 40 Annette M Doherty
$ 31.00 $ 45.00 (-31%)

4.3

18 reviews

Annual Reports In Medicinal Chemistry Vol 40 Annette M Doherty instant download after payment.

Publisher: Elsevier, Academic Press
File Extension: PDF
File size: 4.86 MB
Pages: 1
Author: Annette M. Doherty, Mark G. Bock, Manoj C. Desai, John Overington, Jacob J. Plattner, Andrew Stamford, David Wustrow and Hannah Young (Eds.)
ISBN: 9780120405404, 0120405407
Language: English
Year: 2005

Product desciption

Annual Reports In Medicinal Chemistry Vol 40 Annette M Doherty by Annette M. Doherty, Mark G. Bock, Manoj C. Desai, John Overington, Jacob J. Plattner, Andrew Stamford, David Wustrow And Hannah Young (eds.) 9780120405404, 0120405407 instant download after payment.

Annual Reports in Medicinal Chemistry continues to strive to provide timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences which are expected to provide the basis for entirely new future therapies.Volume 34 retains the familiar format of previous volumes, this year with 33 chapters. Sections I-IV are disease-oriented and generally report on specific medicinal agents with updates from Volume 33 on antithrombotics, neurokinin receptor antagonists, anticoagualants, and new antibacterials. As in past volumes, annual updates have been limited to only the most active areas of research in favor of specifically focused and mechanistically oriented chapters, where the objective is to provide the reader with the most important new results in a particular field. Sections V and VI continue to emphasize important topics in medicinal chemistry, biology, and drug design as well as the critical interfaces among these disciplines. This volume concludes with To Market, To Market-a chapter on NCE and NBE introductions worldwide in 1998, a chapter on pharmagenomics, and finally one on malaria as a third world disease in need of a first world drug development.

Related Products